Data / Form D filings / Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc.: Form D filings
Cartesian Therapeutics, Inc., a biotechnology company in Gaithersburg, MD, filed 16 Form D notices with the SEC between 2010 and 2024. The latest, on July 17, 2024, reports $130 million sold of a $130 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 704 QUINCE ORCHARD RD, Gaithersburg, MD, 20878
- Phone
- (617) 923-1400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1453687
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 17, 2024 | New notice | $130,023,000 | $130,023,000 | 22 | Jul 2, 2024 | sec.gov | |
| Dec 4, 2023 | Amendment | $60,250,000 | $60,250,000 | 2 | Nov 13, 2023 | sec.gov | |
| Dec 1, 2023 | New notice | $60,250,000 | $60,250,000 | 2 | Nov 13, 2023 | sec.gov | |
| Aug 18, 2020 | New notice | $25,000,000 | $25,000,000 | 1 | Jul 31, 2020 | sec.gov | |
| Jan 2, 2020 | New notice | $70,000,000 | $70,000,000 | 26 | Dec 18, 2019 | sec.gov | |
| Sep 4, 2019 | New notice | $5,752,495 | $5,752,495 | 10 | Aug 20, 2019 | sec.gov | |
| Jul 11, 2017 | New notice | $50,000,000 | $50,000,000 | 11 | Jun 27, 2017 | sec.gov | |
| Dec 14, 2016 | New notice | $4,999,984 | $4,999,984 | 1 | Dec 2, 2016 | sec.gov | |
| Sep 10, 2015 | New notice | $40,637,943 | $37,400,000 | $3,237,943 | 19 | Aug 27, 2015 | sec.gov |
| Apr 23, 2015 | New notice | $7,500,000 | $5,942,306 | $1,557,694 | 12 | Apr 10, 2015 | sec.gov |
| Aug 28, 2014 | New notice | $4,450,000 | $4,450,000 | 11 | Aug 14, 2014 | sec.gov | |
| Jul 15, 2014 | New notice | $6,000,000 | $6,000,000 | 2 | Jul 15, 2014 | sec.gov | |
| Apr 9, 2014 | New notice | $9,999,994 | $5,292,702 | $4,707,292 | 11 | Apr 7, 2014 | sec.gov |
| Nov 17, 2011 | New notice | $26,000,000 | $3,500,000 | $22,500,000 | 1 | Nov 7, 2011 | sec.gov |
| Nov 17, 2011 | New notice | $22,000,000 | $22,000,000 | 16 | Nov 7, 2011 | sec.gov | |
| Apr 6, 2010 | New notice | $15,000,006 | $15,000,006 | 14 | Mar 22, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chris A. Jewell | Executive Officer | |
| Michael C. Singer | Director | |
| Kemal C. Malik | Director | |
| Carsten Brunn | Executive Officer, Director | |
| Metin A. Kurtoglu | Executive Officer | |
| Timothy C. Barabe | Director | |
| Timothy A. Springer | Director | |
| Nishan C. de Silva | Director | |
| Patrick A. Zenner | Director | |
| Emily A. English | Executive Officer | |
| Carrie S. Cox | Director | |
| Blaine Davis | Executive Officer | |
| Murat C. Kalayoglu | Director | |
| Milos A. Miljkovic | Executive Officer |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jul 15, 2024 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cartesian Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.